Ahead of Ireland’s first psychedelic research conference, Dr Colm Harrington outlines what the current science says on psychedelic-assisted therapy...
Vous n'êtes pas connecté
As mounting evidence supports the potential of psychedelic-assisted therapies, the FDA nears a groundbreaking decision: the approval of psilocybin, the
Ahead of Ireland’s first psychedelic research conference, Dr Colm Harrington outlines what the current science says on psychedelic-assisted therapy...
Near-infrared therapy is emerging as a promising treatment for brain injuries, offering new hope for recovery by enhancing healing and reducing...
Fat-Derived cellular therapy offers a promising new approach for diabetes, using cells from body fat to improve insulin function and potentially...
A glaucoma medication, methazolamide, has been found to reduce the accumulation of tau protein in zebrafish and mice, offering potential hope for...
Medical collab PARASOL has broadened potential surrogate endpoints for FDA approval of treatments for a rare kidney disease treatment, potentially ...
The first patient to receive gene therapy for sickle cell disease since its approval is finally home. The New York Times reported that staff members...
Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...
Even as cancer remains a leading cause of death globally, bacteria-based cancer therapy presents an exciting and innovative treatment option. Owing to...
Insomnia therapy for expecting mothers can significantly reduce the risk of postpartum depression, promoting better sleep and emotional health for...
CAMBRIDGE, Mass.--(BUSINESS WIRE) October 29, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company,...